Prediction of recrystallization behavior of troglitazone/polyvinylpyrrolidone solid dispersion by solid-state NMR

International Journal of Pharmaceutics

Volumn 383, Issue 1-2, 2010, Pages 18-23

  Ito, Atsutoshi ^a   Watanabe, Tomoyuki ^a   Yada, Shuichi ^a   Hamaura, Takeshi ^a   Nakagami, Hiroaki ^a   Higashi, Kenjirou ^b   Moribe, Kunikazu ^b   Yamamoto, Keiji ^b  

^a DAIICHI SANKYO CO   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Partial least squares regression; Physical stability; Recrystallization; Solid dispersion; Solid state NMR

Indexed keywords

POVIDONE; SOLVENT; TROGLITAZONE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG STORAGE; GRINDING; KINETICS; MOLECULAR DYNAMICS; PHYSICAL CHEMISTRY; POLARIZATION; PREDICTION; PRIORITY JOURNAL; X RAY DIFFRACTION;

CHROMANS; CRYSTALLIZATION; MAGNETIC RESONANCE SPECTROSCOPY; POVIDONE; PREDICTIVE VALUE OF TESTS; THIAZOLIDINEDIONES; X-RAY DIFFRACTION;

EID: 70449519077     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.08.037     Document Type: Article

References (25)

1. Berendt R.T., Sperger D.M., Isbester P.K., and Munson E.J. Solid-state NMR spectroscopy in pharmaceutical research and analysis. Trends Anal. Chem. 25 (2006) 977-984
2. Crowley K.J., and Zografi G. The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state. Pharm. Res. 20 (2003) 1417-1422
3. 19F CP/MAS NMR. J. Pharm. Sci. 96 (2007) 264-267
4. Gustafsson C., Lennholm H., Iversen T., and Nystrom C. Comparison of solid-state NMR and isothermal microcalorimetry in the assessment of the amorphous component of lactose. Int. J. Pharm. 174 (1998) 243-252
5. Haaland D.M., and Thomas E. Partial least-squares method for spectral analyses. 1. Relation to other quantitative calibration methods and the extraction of qualitative information. Anal. Chem. 60 (1988) 1193-1202
6. Hancock B.C., and Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86 (1997) 1-12
7. Hasegawa S., Hamaura T., Furuyama N., Kusai A., Yonemochi E., and Terada K. Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method. Int. J. Pharm. 302 (2005) 103-112
8. Heinz A., Savolainen M., Rades T., and Strachan C.J. Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy. Eur. J. Pharm. Sci. 32 (2007) 182-192
9. Kachrimanis K., Braun D.E., and Griesser U.J. Quantitative analysis of paracetamol polymorphs in powder mixtures by FT-Raman spectroscopy and PLS regression. J. Pharm. Biomed. Anal. 43 (2007) 407-412
10. Law D., Krill S.L., Schmitt E.A., Fort J.J., Qiu Y., Wang W., and Porter W.R. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions. J. Pharm. Sci. 90 (2001) 1015-1025
11. Miyazaki T., Yoshioka S., Aso Y., and Kawanishi T. Crystallization rate of amorphous nifedipine analogues unrelated to the glass transition temperature. Int. J. Pharm. 336 (2007) 191-195
12. Price C.W. Use of Kolmogorov-Johnson-Mehl-Avrami kinetics in recrystallization of metals and crystallization of metallic glasses. Acta Metall. Mater. 38 (1990) 727-738
13. Roggo Y., Chalus P., Maurer L., Lema-Martinez C., Edmond A., and Jent N. A review of near infrared spectroscopy and chemometrics in pharmaceutical technologies. J. Pharm. Biomed. Anal. 44 (2007) 683-700
14. Shah B., Kakumanu V.K., and Bansal A.K. Analytical techniques for quantification of amorphous/crystalline phase in pharmaceutical solids. J. Pharm. Sci. 95 (2006) 1641-1665
15. Sheth A.R., Lubach J.W., Munson E.J., Muller F.X., and Grant D.J.W. Mechanochromism of piroxicam accompanied by intermolecular proton transfer probed by spectroscopic methods and solid-phase changes. J. Am. Chem. Soc. 127 (2005) 6641-6651
16. 13C CPMAS NMR quantitation of charred and uncharred wood. Solid State Nucl. Magn. Reson. 22 (2002) 71-82
17. Tishmack P.A., Bugay D.E., and Byrn S.R. Solid-state nuclear magnetic resonance spectroscopy-pharmaceutical applications. J. Pharm. Sci. 92 (2003) 441-474
18. Usui F., Maeda K., Kusai A., Ikeda M., Nishimura K., and Yamamoto K. Dissolution improvement of RS-8359 by solid dispersion prepared by the solvent method. Int. J. Pharm. 170 (1998) 247-256
19. Vippagunta S.R., Maul K.A., Tallavajhala S., and Grant D.J.W. Solid-state characterization of nifedipine solid dispersions. Int. J. Pharm. 236 (2002) 111-123
20. Watanabe T., Wakiyama N., Usui F., Ikeda M., Isobe T., and Senna M. Stability of amorphous indomethacin compounded with silica. Int. J. Pharm. 226 (2001) 81-91
21. 13C solid state NMR. Int. J. Pharm. 248 (2002) 123-129
22. Yonemochi E., Kitahara S., Maeda S., Yamamura S., Oguchi T., and Yamamoto K. Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying. Eur. J. Pharm. Sci. 7 (1999) 331-338
23. Yoshihashi Y., Iijima H., Yonemochi E., and Terada K. Estimation of physical stability of amorphous solid dispersion using differential scanning calorimetry. J. Therm. Anal. Calorim. 85 (2006) 689-692
24. Yoshioka M., Hancock B.C., and Zografi G. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J. Pharm. Sci. 83 (1994) 1700-1705
25. Yoshioka S., and Aso Y. Correlations between molecular mobility and chemical stability during storage of amorphous pharmaceuticals. J. Pharm. Sci. 96 (2007) 960-981